Androgen replacement therapy in women.

Area of Science:

• Endocrinology
• Women's Health
• Reproductive Medicine

Background:

• Female androgens originate from adrenal and ovarian sources.
• Adrenal insufficiency or oophorectomy can cause severe androgen deficiency.
• Physiological menopause does not uniformly lead to androgen deficiency.

Purpose of the Study:

• To critically evaluate the definition and diagnosis of female androgen deficiency syndrome.
• To review current androgen replacement options and their efficacy.
• To establish criteria for appropriate androgen replacement therapy in women.

Main Methods:

• Literature review of studies on female androgen production, deficiency, and replacement.
• Analysis of diagnostic criteria for female androgen deficiency syndrome.
• Evaluation of clinical trial data for testosterone and dehydroepiandrosterone (DHEA) replacement.

Main Results:

• The definition of female androgen deficiency syndrome requires refinement to avoid overdiagnosis.
• Transdermal testosterone and oral DHEA show improvements in libido and mood.
• Long-term effects on body composition, cardiovascular health, and cancer risk require further documentation.

Conclusions:

• Androgen replacement therapy should be reserved for women with severe, confirmed androgen deficiency and corresponding symptoms.
• Careful patient selection is crucial due to uncertainties in long-term safety profiles.
• Further research is needed to fully understand the long-term implications of androgen replacement.